PD |
Alterations in the levels of Rab1: 2 and 8 and the SNARE protein syntaxin 5 |
Differentiated PC12 cells treated with 6-hydroxydopamine or methamphetamine |
[59] |
|
Prefibrillar aggregates of α-synuclein |
COS-7 cells overexpressing α-synuclein |
[75] |
|
Defects in Rab1 dependent ER-Golgi transport |
Substancia nigra from rats injected with vectors for α-synuclein and Rab1 |
[149] |
|
Enhanced phosphorylation of Rab7L1 by mutant LRKK2 (TGN fragmentation) |
HEK293 cells expressing Rab7L1 and LRRK2 mutant |
[78] |
AD |
Accumulation of Aβ which causes activation of cdk5 and phosphorylation of GRASP65 |
Transgenic mice/CHO cells expressing APP and PS1 mutants |
[60] |
|
Accumulation of phospho-tau |
Neurons from neocortex and hippocamous of AD patients |
[113] |
|
Tau secretion |
Primary cortical neurons |
[112] |
ALS |
Endosomal abnormalities due to altered dynein-dependent transport |
SOD1-ALS mouse |
[120] |
|
Mutations in optineurin |
Motor neuron-like NSC-34 cells |
[131] |
|
Interruption of ARF1/TBCE cross-talk that coordinate COPI formation and microtubule polymerization |
Motor neurons from progressive motor neuropathy mice |
[20] |
|
Rab1-dependent ER-Golgi transport |
Neuro2a cells transfected with TDP-43, FUS or SOD1 |
[130] |
|
Stathmin 1/2-triggered microtubule destabilization |
Transgenic SOD1mutants mouse motor neurons |
[136] |
SMA |
Low levels of α-COP |
SMA patient fibroblasts |
[144] |